Hip Hop Caucus Applauds U.S. Supreme Court’s Unanimous Decision Upholding Access to Widely-Used Abortion Medication

WASHINGTON — Today, Hip Hop Caucus Senior Director of Campaigns and Advocacy Russell Armstrong issued the following statement in response to the U.S. Supreme Court’s unanimous decision rejecting a challenge to the Food and Drug Administration’s rules for prescribing and dispensing abortion pills:

“Our reproductive rights and freedoms, particularly those that reinforce the body autonomy of women, should be expanded and upheld. The U.S. Supreme Court’s unanimous decision in the Food and Drug Administration (FDA) v. Alliance for Hippocratic Medicine case not only reinforces the FDA’s scientific expertise and processes for drug approvals, but will continue to provide a critical resource for those seeking abortions and the right to choose safe options — for now. 

We still have a fight on our hands. Since Roe v. Wade was overturned by the U.S. Supreme Court in 2022, medications like mifepristone, which is used in a majority of U.S. abortions, have become a point of focus for those aiming to curtail reproductive rights. When states like Louisiana are unnecessarily classifying abortion medication as a dangerous narcotic on the same level as Xanax, we must continue organizing state-to-state to make sure reproductive freedom is once again the federal law of the land. 

Abortion access is healthcare and it should be available to all those who desire it regardless of their personal reasons or circumstances. Our most powerful tool to uphold our freedoms and create the change we want to see is to exercise our right to vote. Hip Hop Caucus is committed to supporting community-led advocacy on this issue this election season, and continuing the fight for reproductive freedom until everyone has their full reproductive rights restored.”